510k semaglutide immunoassay Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide and health risk: Development

Semaglutide may silence the food noise in your head Date: September 16, 2025 Source: European Association for the Study of Diabetes Summary: People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health improving

*AEMS is intended to help identify safety concerns related to marketed products, but it does not prove any product or drug is linked or caused a particular side effect or injury

The review also supports the favorable short-term safety of GLP-1 RAs in pediatric populations

Current research focuses on exploring the efficacy of aerobic exercise in MAFLD - related physiological activities and pathological responses

Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026